| [1] |
Fung JJ,Alessiani M,Abu-Elmagd K,et al.Adverse effects associated with the use of FK 506[J].Transplant Proc, 1991,23(6):3 105-3 108.
|
| [2] |
Rosen H,Gonzalez-Cabrera PJ,Sanna MG,et al.Sphingosine 1-phosphate receptor signaling[J].Annu Rev Biochem,2009,78(1):743-768.
|
| [3] |
Oo ML,Chang SH,Thangada S,et al.Engagement of S1P(1)-degradative mechanisms leads to vascular leak in mice[J].J Clin Invest,2011,121(6):2 290-2 300.
|
| [4] |
Oo ML,Thangada S,Wu MT,et al.Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor[J].J Biol Chem,2007,282(12):9 082-9 089.
|
| [5] |
Chiba K.FTY720,a new class of immunomodulator,inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors[J].Pharmacol Ther,2005,108(3):308-319.
|
| [6] |
Brinkmann V, Billich A, Baumruker T, et al. Fingolimod(FTY720):discovery and development of an oral drug to treat multiple sclerosis[J].Nat Rev Drug Discov,2010,9(11):883-897.
|
| [7] |
Suzuki K,Yan H,Li XK,et al.Prevention of experimentally induced autoimmune type I diabetes in rats by the new immunosuppressive reagent FTY720[J].Transplant Proc,1998,30(4):1 044-1 045.
|
| [8] |
Tsunemi S,Iwasaki T,Kitano S,et al.Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model[J].Clin Immunol,2010,136(2):197-204.
|
| [9] |
Wang F,Tan W,Guo D,et al.Reduction of CD4 positive T cells and improvement of pathological changes of collagen-induced arthritis by FTY720[J].Eur J Pharmacol,2007,573(1/2/3):230-240.
|
| [10] |
Billich A,Bornancin F,Devay P,et al.Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases[J].J Biol Chem,2003,278(48):47 408-47 415.
|
| [11] |
Sanna MG,Liao J,Jo E,et al.Sphingosine 1-phosphate(S1P)receptor subtypes S1P1 and S1P3,respectively,regulate lymphocyte recirculation and heart rate[J].J Biol Chem,2004,279(14):13 839-13 848.
|
| [12] |
Bergsdorf C,Kropp-Goerkis C,Kaehler I,et al.A one-day,dispense-only IP-One HTRF assay for high-throughput screening of Galphaq protein-coupled receptors:towards cells as reagents[J].Assay Drug Dev Technol,2008,6(1):39-53.
|
| [13] |
Trinquet E,Bouhelal R,Dietz M.Monitoring Gq-coupled receptor response through inositol phosphate quantification with the IP-One assay[J].Expert Opin Drug Discov,2011,6(10):981-994.
|
| [14] |
Foss FW,Jr Snyder AH,Davis MD,et al.Synthesis and biological evaluation of gamma-aminophosphonates as potent,subtype-selective sphingosine 1-phosphate receptor agonists and antagonists[J].Bioorg Med Chem,2007,15(2):663-677.
|
| [15] |
Hamada M,Nakamura M,Kiuchi M,et al.Removal of sphingosine 1-phosphate receptor-3(S1P(3))agonism is essential,but inadequate to obtain immunomodulating 2-aminopropane-1,3-diol S1P(1)agonists with reduced effect on heart rate[J].J Med Chem,2010,53(8):3 154-3 168.
|
下载:
